| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JPS.2600840305 |
| P698 | PubMed publication ID | 7616365 |
| P2093 | author name string | G R Peters | |
| J C Fleishaker | |||
| L K Pearson | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenytoin | Q410400 |
| P304 | page(s) | 292-294 | |
| P577 | publication date | 1995-03-01 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Phenytoin causes a rapid increase in 6 beta-hydroxycortisol urinary excretion in humans--a putative measure of CYP3A induction | |
| P478 | volume | 84 |
| Q34979818 | A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity. |
| Q28363552 | A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratio |
| Q77481302 | Comment: troglitazone drug interactions |
| Q43793296 | DEET (N,N-diethyl-m-toluamide) alone and in combination with permethrin increased urinary excretion of 6beta-hydroxycortisol in rats, a marker of hepatic CYP3A induction |
| Q33742243 | Differential kinetics of phenytoin in elderly patients. |
| Q44484816 | Drug interaction potential of soy extract and Panax ginseng |
| Q44415284 | Effect of intrapatient dosage escalation of irinotecan on its pharmacokinetics in pediatric patients who have high-grade gliomas and receive enzyme-inducing anticonvulsant therapy |
| Q36887501 | Experimental models for evaluating enzyme induction potential of new drug candidates in animals and humans and a strategy for their use. |
| Q42106492 | Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteers |
| Q60705900 | Imipramine demethylation in vivo: Impact of CYP1A2, CYP2C19, and CYP3A4* |
| Q74277096 | Liquid chromatographic determination of urinary 6beta-hydroxycortisol to assess cytochrome p-450 3A activity in HIV positive pregnant women |
| Q52575640 | Metabolism of anabolic steroids by recombinant human cytochrome P450 enzymes. Gas chromatographic-mass spectrometric determination of metabolites. |
| Q44237138 | Microsomal enzyme induction and clinical aggravation of porphyria: the evaluation of human urinary 6beta-hydroxycortisol/cortisol ratio as the index of hepatic CYP3A4 activity |
| Q73469872 | Phenytoin and electric shock-induced apoptosis in rat peripheral blood lymphocytes |
| Q35596516 | Population pharmacokinetics of oral high-dose busulfan in adult patients undergoing hematopoietic stem cell transplantation |
| Q47266083 | Population pharmacokinetics of tirilazad: effects of weight, gender, concomitant phenytoin, and subarachnoid hemorrhage |
| Q37271469 | Role of intravenous levetiracetam in seizure prophylaxis of severe traumatic brain injury patients |
| Q48121272 | Seizures and Choice of Antiepileptic Drugs Following Subarachnoid Hemorrhage: A Review |
| Q55426998 | The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo. |
| Q47722116 | Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism |
| Q33588554 | Troglitazone: a review of its use in the management of type 2 diabetes mellitus |
| Q35579020 | Urinary 6?-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals |
Search more.